Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 33.03 Billion CNY | 10.12% |
| 2022 | 30 Billion CNY | 10.46% |
| 2021 | 27.16 Billion CNY | 30.63% |
| 2020 | 20.79 Billion CNY | 6.22% |
| 2019 | 19.57 Billion CNY | 132.64% |
| 2018 | 8.41 Billion CNY | 43.25% |
| 2017 | 5.87 Billion CNY | 21.84% |
| 2016 | 4.82 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 31.67 Billion CNY | 0.0% |
| 2023 Q2 | 31.94 Billion CNY | 0.0% |
| 2023 Q4 | 33.03 Billion CNY | 0.0% |
| 2023 FY | 33.03 Billion CNY | 10.12% |
| 2022 Q4 | 30 Billion CNY | 0.0% |
| 2022 FY | 30 Billion CNY | 10.46% |
| 2022 Q2 | 28.84 Billion CNY | 0.0% |
| 2021 Q4 | 27.16 Billion CNY | 0.0% |
| 2021 FY | 27.16 Billion CNY | 30.63% |
| 2021 Q2 | 25.62 Billion CNY | 0.0% |
| 2020 FY | 20.79 Billion CNY | 6.22% |
| 2020 Q4 | 20.79 Billion CNY | 0.0% |
| 2020 Q2 | 22.05 Billion CNY | 0.0% |
| 2019 FY | 19.57 Billion CNY | 132.64% |
| 2019 Q4 | 19.57 Billion CNY | 0.0% |
| 2019 Q2 | 18.04 Billion CNY | 0.0% |
| 2018 FY | 8.41 Billion CNY | 43.25% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q4 | 8.41 Billion CNY | 0.0% |
| 2017 FY | 5.87 Billion CNY | 21.84% |
| 2016 FY | 4.82 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -3540.81% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | -46.74% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -2466.762% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -1476.962% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -6810.25% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -1042.957% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -1068.467% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -1812.72% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -3814.754% |
| SSY Group Limited | 11.96 Billion HKD | -176.1% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -2279.142% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -847.533% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 87.84% |